Non-communicable diseases: obesity, hypertension, diabetes, dyslipidemia Not Applicable
Conditions
Interventions
Current interventions as of 10/03/2021:
A cohort of identified at-risk children and at-risk teachers from 8 quintile 3 primary schools in Port Elizabeth, South Africa, will be followed-up during a 2
Sponsors
Swiss National Science Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 17/12/2020: 1. Children and teachers from the KaziBantu study population 2. Children aged approximately 10–13 years old (4th to 7th grade) 3. Teachers aged approximately 21–65 years old 4. Children identified for being at high-risk for non-communicable diseases defined as presenting at least: 4.1. Pre- or hypertension 4.2. Pre- or diabetes 4.3. Borderline or hypercholesterolemia 4.4. Overweight or obesity 5. Written informed consent by parent/guardian for children and by teachers Previous inclusion criteria: 1. Children and teachers from the KaziBantu study population 2. Children aged approximately 10–13 years old (4th to 7th grade) 3. Teachers aged approximately 21–65 years old 4. Children and teachers identified for being at high-risk for non-communicable diseases defined as presenting at least: 4.1. Pre- or hypertension 4.2. Pre- or diabetes 4.3. Borderline or hypercholesterolemia 4.4. Overweight or obesity 5. Written informed consent by parent/guardian for children and by teachers
Exclusion criteria
Exclusion criteria: 1. Participation in another clinical trial 2. Lack of written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measure as of 10/03/2021: Assessed 1 and 2 years post KaziBantu intervention: 1. Body weight, assessed using a digital weighing scale 2. Body height, assessed using a stadiometer 3. Body mass index, calculated as weight (kg)/height (m)2 4. Waist and hip circumference, assess using a tape 5. Body fat percentage, assessed using bioelectrical impedance analysis (BIA) 6. Self-reported health status, assessed by questionnaire 7. Blood pressure (systolic and diastolic), assessed using oscillometry with a digital blood pressure monitor 8. Blood lipids (TC, HDL-C, LDL-C, TG, Non-HDL, C-HDL ratio), measured using the Alere Afinion AS100 analyser 9. Blood glucose (HbA1c), measured using the Alere Afinion AS100 analyser 10. Haemoglobin concentration, assessed using the HemoCue Hb 301 system 11. Objectively measured physical activity, assessed using an ActiGraph accelerometer 12. Self-reported physical activity, assessed via the Health-Behaviour of School-Aged Children (HBSC) questionnaire 13. Self-reported diet, assessed via the 24-hour recall questionnaire 14. General health assessment, assessed for teachers via online seminar 15. Implementation status, assessed via questionnaire 16. Feasibility and acceptability, assessed via semi-structured interviews and focus group discussions _____ Previous primary outcome measure: Assessed 1 and 2 years post KaziBantu intervention: 1. Body weight, assessed using a digital weighing scale 2. Body height, assessed using a stadiometer 3. Body mass index, calculated as weight (kg)/height (m)2 4. Waist and hip circumference, assess using a tape 5. Body fat percentage, assessed using bioelectrical impedance analysis (BIA) 6. Physical examination, assessed face-to-face by a professional nurse 7. Self-reported health status, assessed by questionnaire 8. Blood pressure (systolic and diastolic), assessed using oscillometry with a digital blood pressure monitor 9. Blood lipids (TC, HDL-C, LDL-C, TG, Non-HDL, C-HDL r | — |
Secondary
| Measure | Time frame |
|---|---|
| The following control variables will be assessed via questionnaire 1 and 2 years post KaziBantu intervention: 1. Age 2. Sex 3. Socioeconomic status 4. Ethnicity 5. Home language 6. School 7. Grade | — |
Countries
South Africa
Outcome results
None listed